Compared to most health system publications, this report is more difficult to ignore due to a particular aspect of its figures. NHS Resolution examined 105 clinical negligence claims, all of which were completed and paid. In these cases, patients or their families claimed that a general practice failure caused a delay in receiving a cancer diagnosis. nor delays at the hospital. not on waiting lists. The GP consultation stage, as well as the discussions, decisions, and follow-up activities that decide whether someone is referred urgently, slowly, or not at all, are where the failures examined in this research occurred. The study discovered that the 105 incidents were not a haphazard collection of isolated errors. It’s a pattern, and ignoring patterns in medicine can be costly.
65.7 percent is the headline number. This represents the percentage of the 105 patients that were diagnosed with Stage 3 or Stage 4 cancer, which is a late-stage condition with fewer treatment options and a worse chance of survival. Even among the general population, the NHS is not detecting enough cancers early, as evidenced by the national early detection rate for Stages 1-2, which is approximately 54%. However, the population’s tilt is significantly worse. These were individuals whose symptoms appeared early enough to warrant appointments with a general practitioner, but they had already progressed to an advanced stage before a diagnosis was made. The report resides in the space between those two facts.
Important Information
| Field | Details |
|---|---|
| Report Title | Delayed Diagnosis of Cancer: A Thematic Review of General Practice Indemnity Claims |
| Published | October 22, 2025 — by NHS Resolution, an arm’s-length body of the Department of Health and Social Care |
| Scope | 105 completed and settled clinical negligence claims relating to delayed cancer diagnosis in general practice; covers a seven-year period to March 2023 |
| Key Statistic | 65.7% of patients in the reviewed claims were diagnosed at Stage 3 or 4 cancer — compared to national early diagnosis rates of around 54% for Stages 1-2 |
| Remote Consultation Finding | Remote consultations featured in 53% of claims — raising specific questions about history-taking quality and the limitations of diagnosis without physical examination |
| Referral Route | 40% of cancer diagnoses in the claims were made via routine referrals or emergency department attendance rather than urgent suspected cancer (USC) pathways — suggesting the urgency of the presentation was not always recognised |
| Gender Disparity | 73.5% of claimants aged under 50 were female — indicating a possible pattern of under-recognition of early-onset cancer in younger women |
| Top 5 Cancer Types in Claims | Colorectal (20%), skin (18%), breast (13%), prostate (13%), urological excluding prostate (9.5%) |
| Jess’s Rule | A principle introduced alongside the report — encourages GP teams to “reflect, review and rethink” when a patient presents three times with the same or escalating symptoms; supported by NHS England and the Royal College of General Practitioners |
| Current NHS Performance | Between May and July 2025, only 53.3% of people with urgent referrals received a cancer diagnosis within the 28-day target — well below the 75% NHS target |
Fifty-three percent of the claims involve remote consultations. This is a finding that should be given more consideration than it usually gets when discussing the digital transformation of the NHS. During the epidemic, telephone and video consultations increased significantly, and they continue to be a significant portion of the workload for general practitioners. The reasons for this are clear: efficiency, patient preference, and capacity. However, a phone conversation cannot identify mild symptoms of abdominal distension, a lump in the neck, or a skin lesion that changes color. The paper takes care to avoid portraying remote consultations as intrinsically flawed. It does point out that they were engaged in 53% of the claims and that the lack of a physical examination alters the information accessible to a general practitioner in ways that necessitate compensation through more thorough history-taking. The research raises the question of whether that compensation is occurring consistently, but it is unable to provide a complete answer based solely on claims data.
The number that will probably cause the most debate among clinicians is the 40 percent figure for routine and emergency referrals as opposed to urgent suspected cancer pathways. Because time is of the essence in oncology, urgent suspected cancer channels are in place to expedite patients’ access to diagnostic services. When a patient receives a diagnosis through an ER visit or a standard referral, it frequently indicates that the urgency was not recognized at the time of GP contact. It can indicate that the presentation was unusual. It can indicate that the patient reduced their symptoms. It can indicate that the general practitioner lacked sufficient information or evaluated it differently than another professional. Individual cases are not blamed in the study. It does point out that this pathway failure occurs in a significant minority of claims and that the learning is in knowing where the decision went differently.
NHS Trust Faces Lawsuit Over Delayed AI-Cancer DiagnosesThe finding that may cause the greatest distress is the gender and age dimension. 73.5 percent of claimants under 50 were women. This is in line with a more general pattern found in medical literature: younger women who exhibit symptoms are more likely to have those symptoms assigned to anxiety, hormonal variables, or other non-oncological causes in a variety of clinical scenarios. The report cannot definitively determine from the numbers alone if that is occurring in the circumstances covered in this claims data. However, the NHS Resolution explicitly cites the proportion rather than hiding it in an appendix since it is unique enough to merit examination.
Perhaps the most useful suggestion in the package is the Jess’s Rule idea, which was presented with the report. The patient whose cancer was discovered too late and whose repeated presentations were unrelated is the source of the rule’s name. NHS England and the Royal College of General Practitioners have approved the principle, which may be summed up in one sentence: “reflect, review, rethink when a patient returns three times with the same or escalating symptoms.” Neither new technology nor a system change are necessary. It necessitates a clinical attention habit, which the analyzed instances indicate was not always present.
Reading this report in the context of the NHS’s current cancer performance—53.3 percent of urgent referrals were diagnosed within the 28-day target as of mid-2025, compared to a target of 75 percent—makes it difficult to ignore the fact that the operational and claims data describe the same pressure from different perspectives. AI, digital technologies, and the ten-year strategy for NHS modernization are not mentioned in the report. This document discusses 105 individuals who should have received a diagnosis sooner but did not, as well as potential insights for the system that failed to do so.
